Trial
NCT04332523
A Study of JNJ-53718678 in Participants With Hepatic Impairment
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Hepatic Impairment
Intervention
JNJ-53718678
Why stopped
A strategic decision was made to discontinue the study. The decision was not based on a safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-13